XML Standards Provide Rigor and Flexibility for Pharma
The pharma industry has come together to develop technical solutions that speed time-consuming processes and reduce errors that can cause risk to the business and ultimately to patients.
Content Strategy for Pharma: Spend Time on Research, not on Redundant Content
We can no longer afford the costs of traditional, document-based content management in the pharmaceutical industry. We need pharma companies to prioritize content reuse and automation rather than manual, error-prone legacy processes.
Solving Pharma Content Challenges
In The Unique Challenges of Pharma Content, we discuss challenges faced by pharmaceutical companies in the creation and management of content.
The Pharma Content Evolution: Content Reuse and Automation
To help create safe, effective medicines in less time, you must change how you “do” content. You need to harness the power of content reuse and automation. You also need to prepare for digital submissions and AI-based content generation. To do that, you need to move toward a component-based, structured
The Unique Challenges of Pharma Content
Most content challenges are ubiquitous, present in every vertical. Processes that don’t scale. Too much content to manage and yet the exact right content never seems to be at hand. Authors must copy and paste and (inevitably) tweak content, wasting time and increasing risk. The challenges of time, cost, and
COVID and Content: The Role of Content in Getting Vaccines to Market Quickly
The COVID-19 pandemic put tremendous pressure on drug-development organizations to accelerate product development far beyond anyone’s wildest roadmaps.
What Is a Reuse Map?
A reuse map is a blueprint for planned content reuse. Planned content reuse means that you identify ahead of time exactly which pieces of content will be reused in a specific output.
MedTech: The Time is Now for Structured Content
I recently came across a great commentary in the August 2021 issue of “Pharma Technology Focus.” The article is titled, “MDR set to transform how MedTech firms approach content management,” written by Barbara Peraltor, Director of Life Science Solutions at Amplexor.
Solving the 6 Challenges of Medical Device Content
EU Medical Device Regulation (2017/745) and In Vitro Diagnostic Regulation (2017/746) went into effect in May 2021, after about a year’s delay due to COVID-19. Medical device manufacturers have known about the new regulations for years and have been working to meet these new, more stringent standards.
Is Structured Content Ready for Pharma?
I’ve had more than one conversation over the past several years about whether pharmaceutical companies were “ready” for structured content. After all, many of the benefits of structured content roll up into one key business need: scale. And scale — the ability to produce a lot of content quickly, accurately,
Buy this Book to learn exactly what it takes to deliver personalized experiences at scale.
our recent posts
Get exclusive access to Val’s thoughts and hand-picked content with our newsletter.
“*” indicates required fields
browse by topic
- Additional Resources (3)
- AI Readiness (9)
- Artificial Intelligence (4)
- Blogs (117)
- Books (1)
- Content Development (45)
- Content Management (4)
- Content Quality (19)
- Content Strategy (99)
- Content Transformation (22)
- Conversational AI (1)
- eBooks (6)
- Global Readiness (5)
- Good Words (2)
- Knowledge Management (1)
- Personalization (19)
- Pharmaceutical (31)
- Recordings (14)
- Regulatory Compliance (1)
- Structured Content (3)
- White Papers (5)
- Workplace Practices (1)